AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and, S. 2123. and H.R. 5771, The Charitable Giving Tax Deduction Act. H.R. 1337, Legacy IRA Act respecting charitable giving and life income planning.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSALIE ABBOTT | — |
| OKEYSHA BROOKS-COLEY | — |
| GREGG HAIFLEY | — |
| RACHEL MARCUS | — |
| CAROLINE POWERS | — |
Health Issues HCR
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on patient access to medical records. Draft legislation on FDA regulation of laboratory tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSALIE ABBOTT | — |
| OKEYSHA BROOKS-COLEY | — |
| GREGG HAIFLEY | — |
| GRETA JOHNSON | — |
| STEPHANIE KRENRICH | — |
| RACHEL MARCUS | — |
| EMILY MYATT | — |
| MATTHEW PHELAN | — |
| CAROLINE POWERS | — |
| PHYLICIA L WOODS | — |
Medicare/Medicaid MMM
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.HR 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on establishment of Medicaid payment for patient navigation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSALIE ABBOTT | — |
| OKEYSHA BROOKS-COLEY | — |
| GREGG HAIFLEY | — |
| STEPHANIE KRENRICH New | — |
| RACHEL MARCUS | — |
| EMILY MYATT | — |
| CAROLINE POWERS | — |
| PHYLICIA L WOODS New | — |
Budget/Appropriations BUD
Federal budget and appropriations for cancer research and programs, including: HR 1625, The Consolidated Approp. Act of 2018 respecting FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act; and issues relating to veterans cancer screenings with respect to the Military Construction and Veterans Affairs Appropriations Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSALIE ABBOTT | — |
| OKEYSHA BROOKS-COLEY | — |
| GREGG HAIFLEY | — |
| GRETA JOHNSON | — |
| RACHEL MARCUS | — |
| CAROLINE POWERS | — |
| EMILY WHITE | — |
Tobacco TOB
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 and FY19 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSALIE ABBOTT | — |
| OKEYSHA BROOKS-COLEY | — |
| GREGG HAIFLEY | — |
| RACHEL MARCUS | — |
| CAROLINE POWERS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.